Prescribing Information
HCP Site
Sign up for emails

Approved use for Talicia

Talicia is indicated for the treatment of Helicobacter pylori infection in adults

Why Talicia?
Savings
What is H. pylori?
Patient Resources
- Patient Resources
- FAQ

Why Talicia?
▽
Savings
What is H. pylori?
▽
Patient Resources
▽
- Patient Resources
- FAQ

Three medications in an all-in-one
capsule

rhb-105-graphic

Find out how effective Talicia is at getting rid of H. pylori

+ -

Important Safety Information About Talicia

Tell your healthcare provider about all of the medicines you take, including prescription or non-prescription medications or herbal supplements before starting Talicia. Talicia may affect the way other medicines work, and other medicines may affect the way Talicia works. Do not start any new medications while taking Talicia without first speaking with your healthcare provider.

You should not take Talicia if you are known to be sensitive to any of the components of Talicia (omeprazole, amoxicillin, rifabutin), penicillins, proton pump inhibitors or rifamycins.
You should not take Talicia if you are taking rilpivirine-containing products, delavirdine or voriconazole.

Before you take Talicia, tell your healthcare provider about all of your medical conditions, including if you:

Are pregnant or plan to become pregnant. Talicia may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during your treatment with Talicia.
Have severe kidney disease or liver disease.

When taking Talicia, do not crush or chew capsules. Do not take Talicia with alcohol.

Call your healthcare provider immediately if while taking Talicia you develop:

New rash or other skin changes, muscle or joint pains, swelling of any area of the body, severe flu-like symptoms, difficulty breathing, fever, blood in your urine, increased or decreased urination, drowsiness, confusion, nausea, vomiting, ongoing stomach pain, bloody diarrhea, or if diarrhea continues after therapy is completed, weight gain or changes in your eyesight.

What are the common side effects of Talicia?

The most common side effects of Talicia are diarrhea, headache, nausea, stomach pain, rash, indigestion, mouth or throat pain, vomiting, and vaginal yeast infection. Call your healthcare professional for medical advice about side effects.
Tell your healthcare provider if you experience tiredness, weakness, achiness, headaches, dizziness, depression, increased sensitivity to light, or pain when taking a deep breath.
Talicia may reduce the effectiveness of oral or other forms of hormonal birth-control. You should use an additional non-hormonal highly effective method of birth control while taking Talicia.
You may experience a brown-orange discoloration of your urine or tears while taking Talicia.
The information here is not comprehensive. Talk to your healthcare provider to learn more.

APPROVED USE FOR TALICIA

TALICIA is a prescription medicine for the treatment of a bacteria, Helicobacter pylori (H. pylori), in the stomach of adults.

Click here for the full Prescribing Information for TALICIA.

You are encouraged to report Adverse Reactions to RedHill Biopharma Inc. at 1-833-ADRHILL (1-833-237-4455) or the FDA at
1-800-FDA-1088 or www.fda.gov/medwatch.

This site is intended for US Consumers only.

The information on this website should not take the place of talking to your doctor or healthcare professional. If you have any questions about your condition, or if you would like more information about TALICIA, or about H. pylori infection, talk to your doctor or pharmacist. Only you and your doctor can decide if TALICIA is right for you.

RedHill Biopharma Inc. (U.S. Office)
8311 Brier Creek Pkwy, Suite 105-161
Raleigh, NC 27617
Tel: +1-984-444-7010
Fax: +1-919-800-3403
info@redhillus.com

Contact Us
RedHill Biopharma US Corporate Site
Privacy Policy
Terms of Use
Sitemap
Sitemap
Prescribing Information

Trademarks are owned by or licensed to RedHill Biopharma Inc. or its related companies.

©2023 RedHill Biopharma Ltd. All rights reserved. US-TAL-342 12/2023

The information on the following site is intended for US health care professionals. Please choose:

I am not a US health care professional

I am a US health care professional